News Coverage 08.05.19 By: John Carroll Share on Twitter Share on Facebook Share on LinkedIn Close to a decade after Eli Lilly killed it, Jeffrey Bluestone’s ‘breakthrough’ drug is back and being steered to the FDA Related Announcement PICI Network Presenters at #KScelltherapy23 Our Impact 2022 Year in Review Announcement PICI Network Researchers to Present at #ASH22